Thursday's announcement is the latest attempt by the Trump administration to rein in soaring drug prices in its efforts to address cost-of-living concerns among voters.
Canadian experts address causes, management, diverse clinical presentations across different ethnicities and need for clinical guidelines to better inform healthcare providers.